New Delhi: Drug maker Lupine on Wednesday said its European arm has completed the acquisition of two brands from Sanofi.
Lupine Atlantis Holdings SA has completed the acquisition of Arane in Germany and Nalcrom in Canada and the Netherlands as well as the trademark rights related to Sanofi, the Mumbai-based drugmaker said in a statement.
It said the transaction is in line with the company's strategy to expand its global presence in specific regions.
It said the acquisition will enhance Lupin's respiratory business in Germany by aiding the expansion of newly established franchisees, following the launch of Luforbac.
Fabrice Agros, President, Corporate Development, Lupine, said, “This acquisition will strengthen our global position in treating patients suffering from a variety of respiratory diseases and conditions, and it adds supporting assets in gastro-intestinal care to our portfolio of branded products. Makes it wider."
Arane (sodium cromoglycate/reproterol hydrochloride pressurized inhalation) is a cromone complex indicated in the symptomatic acute treatment of sudden asthma attacks.
Nalcrom (sodium cromoglycate oral) is used to treat food allergies after adequate testing to limit the main allergens as well as sensitivity to specific allergens.
Lupine shares were trading 3.21 per cent higher at Rs 1,613.45 on BSE.
Lupine Atlantis Holdings SA has completed the acquisition of Arane in Germany and Nalcrom in Canada and the Netherlands as well as the trademark rights related to Sanofi, the Mumbai-based drugmaker said in a statement.
It said the transaction is in line with the company's strategy to expand its global presence in specific regions.
It said the acquisition will enhance Lupin's respiratory business in Germany by aiding the expansion of newly established franchisees, following the launch of Luforbac.
Fabrice Agros, President, Corporate Development, Lupine, said, “This acquisition will strengthen our global position in treating patients suffering from a variety of respiratory diseases and conditions, and it adds supporting assets in gastro-intestinal care to our portfolio of branded products. Makes it wider."
Arane (sodium cromoglycate/reproterol hydrochloride pressurized inhalation) is a cromone complex indicated in the symptomatic acute treatment of sudden asthma attacks.
Nalcrom (sodium cromoglycate oral) is used to treat food allergies after adequate testing to limit the main allergens as well as sensitivity to specific allergens.
Lupine shares were trading 3.21 per cent higher at Rs 1,613.45 on BSE.
